Literature DB >> 19337405

Role of VEGF in organogenesis.

Jody J Haigh1.   

Abstract

The cardiovascular system, consisting of the heart, blood vessels and hematopoietic cells, is the first organ system to develop in vertebrates and is essential for providing oxygen and nutrients to the embryo and adult organs. Work done predominantly using the mouse and zebrafish as model systems has demonstrated that Vascular Endothelial Growth Factor (VEGF, also known as VEGFA) and its receptors KDR (FLK1/VEGFR2), FLT1 (VEGFR1), NRP1 and NRP2 play essential roles in many different aspects of cardiovascular development, including endothelial cell differentiation, migration and survival as well as heart formation and hematopoiesis. This review will summarize the approaches taken and conclusions reached in dissecting the role of VEGF signalling in vivo during the development of the early cardiovasculature and other organ systems. The VEGF-mediated assembly of a functional vasculature is also a prerequisite for the proper formation of other organs and for tissue homeostasis, because blood vessels deliver oxygen and nutrients and vascular endothelium provides inductive signals to other tissues. Particular emphasis will therefore be placed in this review on the cellular interactions between vascular endothelium and developing organ systems, in addition to a discussion of the role of VEGF in modulating the behavior of nonendothelial cell populations.

Entities:  

Keywords:  Cre-loxP system; VEGF; VEGF receptors; angiogenesis; cardiovascular; conditional mutagenesis; mouse; organogenesis

Year:  2008        PMID: 19337405      PMCID: PMC2634330          DOI: 10.4161/org.4.4.7415

Source DB:  PubMed          Journal:  Organogenesis        ISSN: 1547-6278            Impact factor:   2.500


  98 in total

1.  Expression of vascular endothelial growth factor receptors in smooth muscle cells.

Authors:  A Ishida; J Murray; Y Saito; C Kanthou; O Benzakour; M Shibuya; E S Wijelath
Journal:  J Cell Physiol       Date:  2001-09       Impact factor: 6.384

2.  A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function.

Authors:  F J Giordano; H P Gerber; S P Williams; N VanBruggen; S Bunting; P Ruiz-Lozano; Y Gu; A K Nath; Y Huang; R Hickey; N Dalton; K L Peterson; J Ross; K R Chien; N Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

3.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

4.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.

Authors:  G H Fong; J Rossant; M Gertsenstein; M L Breitman
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

5.  Differential expression of VEGF isoforms in mouse during development and in the adult.

Authors:  Y S Ng; R Rohan; M E Sunday; D E Demello; P A D'Amore
Journal:  Dev Dyn       Date:  2001-02       Impact factor: 3.780

Review 6.  Cell fate decisions in early blood vessel formation.

Authors:  Masatsugu Ema; Janet Rossant
Journal:  Trends Cardiovasc Med       Date:  2003-08       Impact factor: 6.677

7.  VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.

Authors:  Hans-Peter Gerber; Ajay K Malik; Gregg P Solar; Daniel Sherman; Xiao Huan Liang; Gloria Meng; Kyu Hong; James C Marsters; Napoleone Ferrara
Journal:  Nature       Date:  2002-06-27       Impact factor: 49.962

8.  VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.

Authors:  Mimoun Azzouz; G Scott Ralph; Erik Storkebaum; Lucy E Walmsley; Kyriacos A Mitrophanous; Susan M Kingsman; Peter Carmeliet; Nicholas D Mazarakis
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

9.  A requirement for neuropilin-1 in embryonic vessel formation.

Authors:  T Kawasaki; T Kitsukawa; Y Bekku; Y Matsuda; M Sanbo; T Yagi; H Fujisawa
Journal:  Development       Date:  1999-11       Impact factor: 6.868

10.  Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression.

Authors:  L Miquerol; B L Langille; A Nagy
Journal:  Development       Date:  2000-09       Impact factor: 6.868

View more
  39 in total

1.  An anteroposterior wave of vascular inhibitor downregulation signals aortae fusion along the embryonic midline axis.

Authors:  Robert J Garriock; Catherine Czeisler; Yasuo Ishii; Alicia M Navetta; Takashi Mikawa
Journal:  Development       Date:  2010-11       Impact factor: 6.868

2.  Increased neovascularization in mice lacking tissue inhibitor of metalloproteinases-3.

Authors:  Quteba Ebrahem; Jian Hua Qi; Masahiko Sugimoto; Mariya Ali; Jonathan E Sears; Alecia Cutler; Rama Khokha; Amit Vasanji; Bela Anand-Apte
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-03       Impact factor: 4.799

3.  A Dosing Study of Bevacizumab for Retinopathy of Prematurity: Late Recurrences and Additional Treatments.

Authors:  David K Wallace; Trevano W Dean; Mary Elizabeth Hartnett; Lingkun Kong; Lois E Smith; G Baker Hubbard; Mary Lou McGregor; Catherine O Jordan; Iason S Mantagos; Edward F Bell; Raymond T Kraker
Journal:  Ophthalmology       Date:  2018-06-07       Impact factor: 12.079

4.  Modeling of growth factor-receptor systems from molecular-level protein interaction networks to whole-body compartment models.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Aleksander S Popel
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 5.  Blood vessel crosstalk during organogenesis-focus on pancreas and endothelial cells.

Authors:  D Berfin Azizoglu; Ondine Cleaver
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-06-21       Impact factor: 5.814

6.  Endothelial cell activation in a VEGF-A gradient: relevance to cell fate decisions.

Authors:  Ann Akeson; Amanda Herman; Diane Wiginton; James Greenberg
Journal:  Microvasc Res       Date:  2010-02-06       Impact factor: 3.514

Review 7.  Advances in understanding and management of retinopathy of prematurity.

Authors:  Mary Elizabeth Hartnett
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

Review 8.  Convergence of VEGF and YAP/TAZ signaling: Implications for angiogenesis and cancer biology.

Authors:  Ameer L Elaimy; Arthur M Mercurio
Journal:  Sci Signal       Date:  2018-10-16       Impact factor: 8.192

9.  TP53-dependent autophagy links the ATR-CHEK1 axis activation to proinflammatory VEGFA production in human bronchial epithelial cells exposed to fine particulate matter (PM2.5).

Authors:  Xiuduan Xu; Hongli Wang; Shasha Liu; Chen Xing; Yang Liu; Wei Zhou; Xiaoyan Yuan; Yongfu Ma; Meiru Hu; Yongliang Hu; Shuxian Zou; Ye Gu; Shuangqing Peng; Shengtao Yuan; Weiping Li; Yuanfang Ma; Lun Song
Journal:  Autophagy       Date:  2016-07-27       Impact factor: 16.016

Review 10.  Safe handling of oral antineoplastic medications: Focus on targeted therapeutics in the home setting.

Authors:  Yaakov Cass; Thomas H Connor; Alexander Tabachnik
Journal:  J Oncol Pharm Pract       Date:  2016-03-22       Impact factor: 1.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.